Author

A. W. Baird

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

N. F. Fletcher· 2 shared C. S. McKimmie· 1 shared C. Shannon-Lowe· 1 shared D. A. Lefteri· 1 shared D. Bailey· 1 shared D. Folan· 1 shared D. Goncalves-Carneiro· 1 shared D. Scholz· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

N. F. Fletcher

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A novel antiviral formulation inhibits SARS-CoV-2 infection of human bronchial epithelium

K. Purves, R. Haverty, T. O'Neill, D. Folan, S. O'Reilly, A. W. Baird, D. Scholz, P. W. Mallon, V. Gautier, M. Folan, N. F. Fletcher

This study demonstrates that ViruSAL inhibits SARS-CoV-2 infection in human bronchial epithelial cells and rat models without causing toxicity.

bioRxiv · Oct 5, 2022 · PreprintPharmacology & Toxicology

A novel antiviral formulation inhibits a range of enveloped viruses.

N. F. Fletcher, L. W. Meredith, E. L. Tidswell, S. R. Bryden, D. Goncalves-Carneiro, Y. Chaudhry, C. Shannon-Lowe, M. A. Folan, D. A. Lefteri, M. Pingen, D. Bailey, C. S. McKimmie, A. W. Baird

This study evaluates a novel antiviral formulation, ViroSAL, which inhibits multiple enveloped viruses in vitro and in vivo by disrupting viral envelopes.

bioRxiv · Mar 29, 2020Microbiology